Editorial
|
| Targeting IL17 for pancreatic cancer prevention |
|
https://doi.org/10.18632/oncotarget.2618
|
| 9530-9531 |
|
| Rethinking glioma treatment strategy |
|
https://doi.org/10.18632/oncotarget.2619
|
| 9532-9533 |
Reviews
|
| How mRNA is misspliced in acute myelogenous leukemia AML |
|
https://doi.org/10.18632/oncotarget.2304
|
| 9534-9545 |
|
| AXL kinase as a novel target for cancer therapy |
|
https://doi.org/10.18632/oncotarget.2542
|
| 9546-9563 |
|
| Inhibition of STAT5: A therapeutic option in BCRABL1driven leukemia |
|
https://doi.org/10.18632/oncotarget.2465
|
| 9564-9576 |
Priority Research Papers
|
| The nuclear import of ribosomal proteins is regulated by mTOR |
|
https://doi.org/10.18632/oncotarget.2473
|
| 9577-9593 |
|
| Chromatin remodelers HELLS and UHRF1 mediate the epigenetic deregulation of genes that drive retinoblastoma tumor progression |
|
https://doi.org/10.18632/oncotarget.2468
|
| 9594-9608 |
Clinical Research Papers
|
| Melanoma patientderived xenografts accurately model the disease and develop fast enough to guide treatment decisions |
|
https://doi.org/10.18632/oncotarget.2445
|
| 9609-9618 |
|
| The Hippo transducer TAZ as a biomarker of pathological complete response in HER2positive breast cancer patients treated with trastuzumabbased neoadjuvant therapy |
|
https://doi.org/10.18632/oncotarget.2449
|
| 9619-9625 |
|
| Heterotrimeric Gprotein alpha12 Gα12 subunit promotes oral cancer metastasis |
|
https://doi.org/10.18632/oncotarget.2437
|
| 9626-9640 |
|
| Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions |
|
https://doi.org/10.18632/oncotarget.2438
|
| 9641-9649 |
|
| Increased serum levels of circulating exosomal microRNA373 in receptornegative breast cancer patients |
|
https://doi.org/10.18632/oncotarget.2520
|
| 9650-9663 |
Research Papers
|
| Tumor hypoxia enhances NonSmall Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling |
|
https://doi.org/10.18632/oncotarget.1856
|
| 9664-9677 |
|
| Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence |
|
https://doi.org/10.18632/oncotarget.1936
|
| 9678-9688 |
|
| Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity |
|
https://doi.org/10.18632/oncotarget.2103
|
| 9689-9702 |
|
| SapCDOPSinduced lysosomal cell death synergizes with TMZ in glioblastoma |
|
https://doi.org/10.18632/oncotarget.2232
|
| 9703-9709 |
|
| Diacylglycerol kinase α promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src |
|
https://doi.org/10.18632/oncotarget.2344
|
| 9710-9726 |
|
| Cancerderived immunoglobulin G promotes LPSinduced proinflammatory cytokine production via binding to TLR4 in cervical cancer cells |
|
https://doi.org/10.18632/oncotarget.2359
|
| 9727-9743 |
|
| Caveolin1 is downregulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth |
|
https://doi.org/10.18632/oncotarget.2403
|
| 9744-9755 |
|
| Amifostine alleviates radiationinduced lethal small bowel damage via promotion of 1433σmediated nuclear p53 accumulation |
|
https://doi.org/10.18632/oncotarget.2386
|
| 9756-9769 |
|
| Methylation of miR1553p in mantle cell lymphoma and other nonHodgkin’s lymphomas |
|
https://doi.org/10.18632/oncotarget.2390
|
| 9770-9782 |
|
| Systematic dissection of the mechanisms underlying progesterone receptor downregulation in endometrial cancer |
|
https://doi.org/10.18632/oncotarget.2392
|
| 9783-9797 |
|
| Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.2394
|
| 9798-9810 |
|
| Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma |
|
https://doi.org/10.18632/oncotarget.2443
|
| 9811-9822 |
|
| TM4SF4 overexpression in radiationresistant lung carcinoma cells activates IGF1R via elevation of IGF1 |
|
https://doi.org/10.18632/oncotarget.2450
|
| 9823-9837 |
|
| A novel action mechanism for MPT0G013 a derivative of arylsulfonamide inhibits tumor angiogenesis through upregulation of TIMP3 expression |
|
https://doi.org/10.18632/oncotarget.2451
|
| 9838-9850 |
|
| Prevention of diabetespromoted colorectal cancer by n3 polyunsaturated fatty acids and n3 PUFA mimetic |
|
https://doi.org/10.18632/oncotarget.2453
|
| 9851-9863 |
|
| Comprehensive analysis of long noncoding RNAs in human breast cancer clinical subtypes |
|
https://doi.org/10.18632/oncotarget.2454
|
| 9864-9876 |
|
| Inhibition of SphK1 reduces radiationinduced migration and enhances sensitivity to cetuximab treatment by affecting the EGFR / SphK1 crosstalk |
|
https://doi.org/10.18632/oncotarget.2436
|
| 9877-9888 |
|
| Targeting the DNA replication checkpoint by pharmacologic inhibition of Chk1 kinase: a strategy to sensitize APC mutant colon cancer cells to 5fluorouracil chemotherapy |
|
https://doi.org/10.18632/oncotarget.2475
|
| 9889-9900 |
|
| RNA sequencing identifies specific PIWIinteracting small noncoding RNA expression patterns in breast cancer |
|
https://doi.org/10.18632/oncotarget.2476
|
| 9901-9910 |
|
| Targeting L1 cell adhesion molecule expression using liposomeencapsulated siRNA suppresses prostate cancer bone metastasis and growth |
|
https://doi.org/10.18632/oncotarget.2478
|
| 9911-9929 |
|
| Ibrutinib inhibits SDF1/CXCR4 mediated migration in AML |
|
https://doi.org/10.18632/oncotarget.2479
|
| 9930-9938 |
|
| Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways |
|
https://doi.org/10.18632/oncotarget.2480
|
| 9939-9951 |
|
| Mutational profiles in triplenegative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences |
|
https://doi.org/10.18632/oncotarget.2481
|
| 9952-9965 |
|
| Glipizide an antidiabetic drug suppresses tumor growth and metastasis by inhibiting angiogenesis |
|
https://doi.org/10.18632/oncotarget.2483
|
| 9966-9979 |
|
| HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FUbased chemotherapy |
|
https://doi.org/10.18632/oncotarget.2484
|
| 9980-9991 |
|
| Galectin3 leads to attenuation of apoptosis through Bax heterodimerization in human thyroid carcinoma cells |
|
https://doi.org/10.18632/oncotarget.2486
|
| 9992-10001 |
|
| Srcdependent phosphorylation at Y406 on the thyroid hormone receptor β confers the tumor suppressor activity |
|
https://doi.org/10.18632/oncotarget.2487
|
| 10002-10016 |
|
| Silibinin inhibits aberrant lipid metabolism proliferation and emergence of androgenindependence in prostate cancer cells via primarily targeting the sterol response element binding protein 1 |
|
https://doi.org/10.18632/oncotarget.2488
|
| 10017-10033 |
|
| Activity of the novel mTOR inhibitor Torin2 in Bprecursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation |
|
https://doi.org/10.18632/oncotarget.2490
|
| 10034-10047 |
|
| TERT promoter mutations and gene amplification: Promoting TERT expression in Merkel cell carcinoma |
|
https://doi.org/10.18632/oncotarget.2491
|
| 10048-10057 |
|
| Differential β2adrenergic receptor expression defines the phenotype of nontumorigenic and malignant human breast cell lines |
|
https://doi.org/10.18632/oncotarget.2460
|
| 10058-10069 |
|
| The tyrosine phosphatase PTPRO sensitizes colon cancer cells to antiEGFR therapy through activation of SRCmediated EGFR signaling |
|
https://doi.org/10.18632/oncotarget.2458
|
| 10070-10083 |
|
| HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization |
|
https://doi.org/10.18632/oncotarget.2459
|
| 10084-10099 |
|
| Intratumoral administration of mRNA encoding a fusokine consisting of IFNβ and the ectodomain of the TGFβ receptor II potentiates antitumor immunity |
|
https://doi.org/10.18632/oncotarget.2463
|
| 10100-10113 |
|
| Heptamethine carbocyanine dyemediated nearinfrared imaging of canine and human cancers through the HIF1α/OATPs signaling axis |
|
https://doi.org/10.18632/oncotarget.2464
|
| 10114-10126 |
|
| TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells |
|
https://doi.org/10.18632/oncotarget.2466
|
| 10127-10139 |
|
| Ciclopirox induces autophagy through reactive oxygen speciesmediated activation of JNK signaling pathway |
|
https://doi.org/10.18632/oncotarget.2471
|
| 10140-10150 |
|
| Functional modification of adipocytes by grape seed extract impairs their protumorigenic signaling on colon cancer stem cells and the daughter cancer cells |
|
https://doi.org/10.18632/oncotarget.2467
|
| 10151-10169 |
|
| CCR9/CCL25 expression in nonsmall cell lung cancer correlates with aggressive disease and mediates key steps of metastasis |
|
https://doi.org/10.18632/oncotarget.2526
|
| 10170-10179 |
|
| HS133 a novel fluorescent phosphatidylinositol 3kinase inhibitor as a potential imaging and anticancer agent for targeted therapy |
|
https://doi.org/10.18632/oncotarget.2507
|
| 10180-10197 |
|
| Signaling pathways activation profiles make better markers of cancer than expression of individual genes |
|
https://doi.org/10.18632/oncotarget.2548
|
| 10198-10205 |
Copyright © 2026 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLC
